BOT 5.26% 40.0¢ botanix pharmaceuticals ltd

Ann: New Canine Pilot Study Supports Further AD Investigation, page-10

  1. 32 Posts.
    lightbulb Created with Sketch. 16
    While this does open the opportunity for animal usage, I think the main point here is that with this new formulation we are back looking at human AD is a use case after the previous fail.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.020(5.26%)
Mkt cap ! $725.6M
Open High Low Value Volume
38.5¢ 40.5¢ 37.5¢ $2.083M 5.320M

Buyers (Bids)

No. Vol. Price($)
12 213440 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 319366 13
View Market Depth
Last trade - 13.48pm 30/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.